ClinicalTrials.gov
public full text
Public Domain
Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis
The purpose of this research study to find out if a drug called OctreoScan or DOTATATE can help doctors diagnose people with cardiac sarcoidosis better. OctreoScan and DOTATATE are both approved by the U.S. Food and Drug Administration (FDA) to diagnose certain tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis#1093917
- Cardiac Sarcoidosis Response To Steroids Trial#882400
- Cardiac Sarcoidosis: A Practical Guide for Cardiologists.#1167004
- PET Imaging in Patients With Suspected Cardiac Sarcoidosis#321713
- Beyond the Biopsy: Imaging Frontiers in Cardiac Sarcoidosis.#30567
Record · ID 1384776
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive